高胆固醇血症临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 高胆固醇血症（国际通用名 hypercholesterolemia）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖高血脂、血脂异常等说法。

正在招募的高胆固醇血症新药试验

• A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia

  III 期招募中中国NCT07421297

• Study To Evaluate The Efficacy And Safety Of A Nutritional Supplement Based On Bergamot, Artichoke And Other Ingredients For Reducing Cholesterol Levels In Patients With Hypercholesterolemia (Metachol+)

  不适用招募中西班牙NCT07178769

• Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy

  不适用招募中意大利NCT05430828

• A Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)

  III 期招募中中国NCT07465263

• Healthy Living Anson Study

  不适用招募中美国NCT07126587

• Screening for Familial Hypercholesterolemia in Children

  不适用招募中法国NCT06555120

• HoFH, the International Clinical Collaborators Registry

  不适用招募中美国NetherlandsSouth AfricaNCT04815005

• Investigating The Potential Of A Hay-Aged Cheese To Reduce Cholesterol As Mediated By Changes In The Gut Microbiome

  不适用招募中英国NCT07351175

• Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Bempedoic Acid in Italy

  不适用招募中意大利NCT07374861

• Clinical Exploration Trial of YOLT-101 in the Treatment of Familial Hypercholesterolemia (FH)

  早期 I 期招募中中国NCT06458010

• The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository

  不适用招募中美国NCT01109368

• Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial

  II 期招募中美国NCT06488105